Status:
COMPLETED
A Study to Learn More About How Safe Dienogest is and How Well it Works Under Real World Conditions in Indian Women With Endometriosis
Lead Sponsor:
Bayer
Conditions:
Endometriosis Associated Pelvic Pain
Eligibility:
FEMALE
18+ years
Brief Summary
Endometriosis is a condition that affects women, usually during their reproductive years. In women with endometriosis, the tissue that normally covers the inside of the womb grows outside the womb. Th...
Eligibility Criteria
Inclusion
- Female patients in India at least 18 years of age
- Clinical or surgical diagnosis of endometriosis: Clinical diagnosis by suggestive symptoms and positive finding in imaging study (Chocolate cyst)
- Patients diagnosed with endometriosis associated pelvic pain who have not been previously treated with Dienogest
- Decision to initiate treatment with Dienogest was made as per investigator's routine treatment practice
- Signed informed consent
Exclusion
- Participation in an investigational program with interventions outside of routine clinical practice
- Contra-indications according to the local summary of product characteristics (SPC)
Key Trial Info
Start Date :
May 13 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 23 2024
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04808843
Start Date
May 13 2022
End Date
September 23 2024
Last Update
January 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations
Multiple Locations, India